Windlas’ Financials a tad weaker than peers but prospects strong
ET Intelligence Group: Unlike its name, Windlas Biotech (WBL) is not a biotech company. The Dehradun-based company is a contract manufacturer for over 200 formulation companies and is engaged in trade generics and over-the-counter products of nutraceuticals and health supplements.WBL is rolling out a Rs 402-crore IPO comprising Rs 165 crore of fresh issue and…
